Have you been told that you have fatty liver or NASH?
This is a Phase 2 clinical research study designed to examine the effect of an investigational drug in patients with fatty liver disease, more specifically patients with NASH and some evidence of liver scarring or liver fibrosis.
To qualify you must have:
At least 2 of the following: Type 2 diabetes, obesity, high blood pressure, elevated liver enzymes
At least 18 years of age
NASH or non-alcoholic steatohepatitis
If you qualify, you will receive study related:
Compensation for time and travel
Are you suffering from NASH (Nonalcoholic steatohepatitis)?
We are looking for volunteers with biopsy-proven NASH verified by pathology reading, to evaluate the safety and efficacy of 2 oral doses of an investigational medicine in reducing liver fat.